369 related articles for article (PubMed ID: 35095876)
21. An inflammatory link in atherosclerosis and obesity. Co-stimulatory molecules.
Zirlik A; Lutgens E
Hamostaseologie; 2015; 35(3):272-8. PubMed ID: 26225729
[TBL] [Abstract][Full Text] [Related]
22. Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus.
Zhou T; Hu Z; Yang S; Sun L; Yu Z; Wang G
J Diabetes Res; 2018; 2018():7457269. PubMed ID: 30533447
[TBL] [Abstract][Full Text] [Related]
23. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
Bruno A; Mortara L; Baci D; Noonan DM; Albini A
Front Immunol; 2019; 10():771. PubMed ID: 31057536
[TBL] [Abstract][Full Text] [Related]
24. The Role of Cytokines in the Development of Atherosclerosis.
Fatkhullina AR; Peshkova IO; Koltsova EK
Biochemistry (Mosc); 2016 Nov; 81(11):1358-1370. PubMed ID: 27914461
[TBL] [Abstract][Full Text] [Related]
25. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells.
Young HA; Ortaldo J
Cell Res; 2006 Jan; 16(1):20-4. PubMed ID: 16467872
[TBL] [Abstract][Full Text] [Related]
26. Obesity-associated cancer: an immunological perspective.
Conroy MJ; Dunne MR; Donohoe CL; Reynolds JV
Proc Nutr Soc; 2016 May; 75(2):125-38. PubMed ID: 26567898
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell memory in infection, inflammation and cancer.
Cerwenka A; Lanier LL
Nat Rev Immunol; 2016 Feb; 16(2):112-23. PubMed ID: 26806484
[TBL] [Abstract][Full Text] [Related]
28. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
29. Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.
Parisi L; Bassani B; Tremolati M; Gini E; Farronato G; Bruno A
J Immunol Res; 2017; 2017():4218254. PubMed ID: 28428965
[TBL] [Abstract][Full Text] [Related]
30. Boosting vaccine efficacy the natural (killer) way.
Rydyznski CE; Waggoner SN
Trends Immunol; 2015 Sep; 36(9):536-46. PubMed ID: 26272882
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
Taylor EB; Sasser JM
Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
[TBL] [Abstract][Full Text] [Related]
32. B cells and atherosclerosis.
Srikakulapu P; McNamara CA
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1060-H1067. PubMed ID: 28314764
[TBL] [Abstract][Full Text] [Related]
33. Innate recognition of microbial-derived signals in immunity and inflammation.
Zhang Y; Liang C
Sci China Life Sci; 2016 Dec; 59(12):1210-1217. PubMed ID: 27888386
[TBL] [Abstract][Full Text] [Related]
34. NK cells: elusive players in autoimmunity.
Johansson S; Berg L; Hall H; Höglund P
Trends Immunol; 2005 Nov; 26(11):613-8. PubMed ID: 16118064
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cells as indispensable players and therapeutic targets in autoimmunity.
Shi FD; Zhou Q
Autoimmunity; 2011 Feb; 44(1):3-10. PubMed ID: 20701455
[TBL] [Abstract][Full Text] [Related]
36. Guest editorial: Innate lymphocytes: Development, homeostasis, and disease.
Sciumè G
Cytokine Growth Factor Rev; 2018 Aug; 42():1-4. PubMed ID: 30219180
[No Abstract] [Full Text] [Related]
37. Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
Pierce S; Geanes ES; Bradley T
Front Cell Infect Microbiol; 2020; 10():231. PubMed ID: 32509600
[TBL] [Abstract][Full Text] [Related]
38. Regulation of metabolism by the innate immune system.
Lackey DE; Olefsky JM
Nat Rev Endocrinol; 2016 Jan; 12(1):15-28. PubMed ID: 26553134
[TBL] [Abstract][Full Text] [Related]
39. The Role of Natural Killer Cells in Autoimmune Diseases.
Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
Front Immunol; 2021; 12():622306. PubMed ID: 33717125
[TBL] [Abstract][Full Text] [Related]
40. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus.
Guo H; Xu B; Gao L; Sun X; Qu X; Li X; Liu S; Feng J; Wang J; Tang Y; Yan G; Gao X; Jiang Y
Exp Biol Med (Maywood); 2012 May; 237(5):556-62. PubMed ID: 22547395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
